FDA brags about its massive systems of data collection, learns nothing from them?
https://www.youtube.com/watch?v=70Xhn3K9SlQ&ab_channel=U.S.FoodandDrugAdministration UPDATE: I expanded on the live blog below here, with additional context, and added information on the people at the meeting. I suggest you read the later version for more detail. 1. Almost every member of the advisory committee earns money for their work on vaccines. However only one acknowledged a financial conflict of…
Below is a Wall Street Journal article I am reposting in full–Nass https://www.wsj.com/articles/the-politics-of-hydroxychloroquine-11594831408 OPINION | COMMENTARY The Politics of Hydroxychloroquine Trump touted it, so Biden denounces it. The FDA has suspended a permit for its use. Let doctors decide. By Allysia Finley July 15, 2020 12:43 pm ET Hubert Humphrey began his career as a…
https://www.thegatewaypundit.com/2022/03/breaking-russia-convenes-un-security-council-meeting-present-biolab-evidence-friday-10/
Update March 18: According to an editor of the BMJ, the article linked below is the first BMJ article to receive a Facebook warning. That tells you something! I had earlier read about the theft of documents from the European Medicines Agencies, and what they revealed about the Pfizer BioNTech vaccine’s mRNA manufacturing issues. This…
It is not embarrassing. This is CDC’s MO. They make certain not to collect the necessary information–which frees CDC to spin the story any way they want to: since no one can get hold of the quality data to prove them wrong. https://www.politico.com/news/2021/12/20/cdc-covid-omicron-delta-tracking-525621 “As the world experiences new, more transmissible Covid-19 variants, scientists and health…
Jeff Childers’ Substack 7/18/22 various non-corporate media sources reported that the U.S.’s fifth-largest life insurance provider, Lincoln National, reported +163% claims payouts for 2021: 2019: $500,888,808 2020: $547,940,260 2021: $1,445,350,949 Lincoln’s annual financial report cited “non-pandemic-related morbidity” and “unusual claims adjustments” to explain losses from its group life insurance business. Other public life insurance providers…
Comments are closed.
'The Biopharmaceutical Industry Provides 75% Of The FDA's Drug Review Budget. Is This A Problem?'
https://www.forbes.com/sites/johnlamattina/2018/06/28/the-biopharmaceutical-industry-provides-75-of-the-fdas-drug-review-budget-is-this-a-problem/?sh=156c1b5449ec